Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer's Disease: Oral or Patch?

IŞIK A. T., Soysal P., Yay A.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, cilt.29, sa.8, ss.735-738, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 8
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1177/1533317514536598
  • Dergi Adı: AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.735-738
  • Anahtar Kelimeler: rivastigmine patch, oral rivastigmine, Alzheimer's disease, arrhythmia, hypotension, elderly, TRANSDERMAL PATCH, DOUBLE-BLIND, QT INTERVAL, POPULATION, 6-MONTH
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: Rivastigmine is commonly used for the treatment of Alzheimer's disease (AD). All cholinesterase inhibitors, including rivastigmine, may cause cardiac side effects. The aim of this study is to compare the electrocardiographic (ECG) and hypotensive effects of formulations of rivastigmine.